182 related articles for article (PubMed ID: 11827520)
41. Identification of gp120 binding sites on CXCR4 by using CD4-independent human immunodeficiency virus type 2 Env proteins.
Lin G; Baribaud F; Romano J; Doms RW; Hoxie JA
J Virol; 2003 Jan; 77(2):931-42. PubMed ID: 12502809
[TBL] [Abstract][Full Text] [Related]
42. The human immunodeficiency virus gp120 binding site on CD4: delineation by quantitative equilibrium and kinetic binding studies of mutants in conjunction with a high-resolution CD4 atomic structure.
Moebius U; Clayton LK; Abraham S; Harrison SC; Reinherz EL
J Exp Med; 1992 Aug; 176(2):507-17. PubMed ID: 1500858
[TBL] [Abstract][Full Text] [Related]
43. Sulfated polyanions prevent HIV infection of lymphocytes by disruption of the CD4-gp120 interaction, but do not inhibit monocyte infection.
Lynch G; Low L; Li S; Sloane A; Adams S; Parish C; Kemp B; Cunningham AL
J Leukoc Biol; 1994 Sep; 56(3):266-72. PubMed ID: 7521897
[TBL] [Abstract][Full Text] [Related]
44. Competition of HLA-DR and a beta 2 domain peptide for HIV envelope glycoprotein gp120 binding to CD4.
Autiero M; Houlgatte R; Martin M; Auffray C; Guardiola J; Piatier-Tonneau D
Int Immunol; 1995 Feb; 7(2):191-7. PubMed ID: 7734415
[TBL] [Abstract][Full Text] [Related]
45. Specific interaction of conformational polypeptides derived from HIV gp120 with human T lymphocyte CD4 receptor.
Liu M; Zeng J; Robey FA
Immunol Lett; 1998 Aug; 63(1):27-32. PubMed ID: 9719435
[TBL] [Abstract][Full Text] [Related]
46. Jacalin, a lectin with anti-HIV-1 properties, and HIV-1 gp120 envelope protein interact with distinct regions of the CD4 molecule.
Corbeau P; Haran M; Binz H; Devaux C
Mol Immunol; 1994 Jun; 31(8):569-75. PubMed ID: 8196669
[TBL] [Abstract][Full Text] [Related]
47. The C4 region as a target for HIV entry inhibitors--NMR mapping of the interacting segments of T20 and gp120.
Moseri A; Biron Z; Arshava B; Scherf T; Naider F; Anglister J
FEBS J; 2015 Dec; 282(24):4643-57. PubMed ID: 26432362
[TBL] [Abstract][Full Text] [Related]
48. Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis.
Fenouillet E; Clerget-Raslain B; Gluckman JC; Guétard D; Montagnier L; Bahraoui E
J Exp Med; 1989 Mar; 169(3):807-22. PubMed ID: 2538547
[TBL] [Abstract][Full Text] [Related]
49. CD4-binding regions of human immunodeficiency virus envelope glycoprotein gp120 defined by proteolytic digestion.
Pollard SR; Meier W; Chow P; Rosa JJ; Wiley DC
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11320-4. PubMed ID: 1763044
[TBL] [Abstract][Full Text] [Related]
50. Investigations using photo affinity labeled analogues confirm the binding between sCD4 and the PND of HIV-1, MN.
Dettin M; Scarinci C; Seraglia R; Di Bello C
Biochem Biophys Res Commun; 1997 Dec; 241(2):584-8. PubMed ID: 9425315
[TBL] [Abstract][Full Text] [Related]
51. Binding of full-length HIV-1 gp120 to CD4 induces structural reorientation around the gp120 core.
Ashish ; Garg R; Anguita J; Krueger JK
Biophys J; 2006 Sep; 91(6):L69-71. PubMed ID: 16844755
[TBL] [Abstract][Full Text] [Related]
52. Crystal structure of a fully glycosylated HIV-1 gp120 core reveals a stabilizing role for the glycan at Asn262.
Kong L; Wilson IA; Kwong PD
Proteins; 2015 Mar; 83(3):590-6. PubMed ID: 25546301
[TBL] [Abstract][Full Text] [Related]
53. Identification and structural analysis of residues in the V1 region of CD4 involved in interaction with human immunodeficiency virus envelope glycoprotein gp120 and class II major histocompatibility complex molecules.
Bowman MR; MacFerrin KD; Schreiber SL; Burakoff SJ
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):9052-6. PubMed ID: 1978941
[TBL] [Abstract][Full Text] [Related]
54. Beta-turn Phe in HIV-1 Env binding site of CD4 and CD4 mimetic miniprotein enhances Env binding affinity but is not required for activation of co-receptor/17b site.
Dowd CS; Leavitt S; Babcock G; Godillot AP; Van Ryk D; Canziani GA; Sodroski J; Freire E; Chaiken IM
Biochemistry; 2002 Jun; 41(22):7038-46. PubMed ID: 12033937
[TBL] [Abstract][Full Text] [Related]
55. The role of structural and functional homology between human apolipoprotein A-I and envelope proteins of human immunodeficiency virus type 1 in CD4 receptor binding.
Panin LE; Kostina NE; Lukashev VA
Dokl Biochem Biophys; 2002; 385():209-12. PubMed ID: 12462973
[No Abstract] [Full Text] [Related]
56. On the Physicochemical and Structural Modifications Associated with HIV-1 Subtype B Tropism Transition.
Lamers SL; Fogel GB; Liu ES; Salemi M; McGrath MS
AIDS Res Hum Retroviruses; 2016 Aug; 32(8):829-40. PubMed ID: 27071630
[TBL] [Abstract][Full Text] [Related]
57. The glycan-mediated mechanism on the interactions of gp120 with CD4 and antibody: Insights from molecular dynamics simulation.
Zhang Y; Niu Y; Tian J; Liu X; Yao X; Liu H
Chem Biol Drug Des; 2017 Dec; 90(6):1237-1246. PubMed ID: 28632942
[TBL] [Abstract][Full Text] [Related]
58. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.
Hart TK; Kirsh R; Ellens H; Sweet RW; Lambert DM; Petteway SR; Leary J; Bugelski PJ
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2189-93. PubMed ID: 2006155
[TBL] [Abstract][Full Text] [Related]
59. CD4 binding site antibodies inhibit human immunodeficiency virus gp120 envelope glycoprotein interaction with CCR5.
Raja A; Venturi M; Kwong P; Sodroski J
J Virol; 2003 Jan; 77(1):713-8. PubMed ID: 12477875
[TBL] [Abstract][Full Text] [Related]
60. Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses.
Dey B; Lerner DL; Lusso P; Boyd MR; Elder JH; Berger EA
J Virol; 2000 May; 74(10):4562-9. PubMed ID: 10775592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
